These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 6295671)
1. Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells. Rickinson AB; Finerty S; Epstein MA Clin Exp Immunol; 1982 Nov; 50(2):347-54. PubMed ID: 6295671 [TBL] [Abstract][Full Text] [Related]
2. Infection of leukaemic B lymphocytes by Epstein Barr virus. Doyle MG; Catovsky D; Crawford DH Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253 [TBL] [Abstract][Full Text] [Related]
3. Interaction of Epstein-Barr virus with leukaemic B cells in vitro. II. Cell line establishment from prolymphocytic leukaemia and from Waldenström's macroglobulinaemia. Finerty S; Rickinson AB; Epstein MA; Platts-Mills TA Int J Cancer; 1982 Jul; 30(1):1-7. PubMed ID: 6288575 [TBL] [Abstract][Full Text] [Related]
4. The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement. Melo JV; Foroni L; Brito-Babapulle V; Luzzatto L; Catovsky D Clin Exp Immunol; 1988 Jul; 73(1):23-8. PubMed ID: 3262465 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells]. Koizumi S Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906 [TBL] [Abstract][Full Text] [Related]
6. EB virus induction is associated with B-cell maturation. Crawford DH; Ando I Immunology; 1986 Nov; 59(3):405-9. PubMed ID: 3025081 [TBL] [Abstract][Full Text] [Related]
7. [Studies on transformation of human lymphocytes by Epstein-Barr virus (author's transl)]. Takada K Hokkaido Igaku Zasshi; 1980 Sep; 55(5):447-70. PubMed ID: 6263773 [TBL] [Abstract][Full Text] [Related]
8. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia. Fernandez LA; MacSween JM; Langley GR Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543 [TBL] [Abstract][Full Text] [Related]
9. Activation and immortalization of leukaemic B cells by Epstein-Barr virus. Walls EV; Doyle MG; Patel KK; Allday MJ; Catovsky D; Crawford DH Int J Cancer; 1989 Nov; 44(5):846-53. PubMed ID: 2555307 [TBL] [Abstract][Full Text] [Related]
10. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40. Crawford DH; Catovsky D Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945 [TBL] [Abstract][Full Text] [Related]
11. Mitogenic stimulation of malignant B cells. Chronic lymphocytic leukaemia: relationship between stimulation and surface phenotype. Bloem AC; Bast EJ; Gmelig Meyling FH; DeGast GC; Ballieux RE Clin Exp Immunol; 1982 Nov; 50(2):355-9. PubMed ID: 6983937 [TBL] [Abstract][Full Text] [Related]
12. Resting B-cells, EBV-infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns. Szekely L; Pokrovskaja K; Jiang WQ; Selivanova G; Löwbeer M; Ringertz N; Wiman KG; Klein G Oncogene; 1995 May; 10(9):1869-74. PubMed ID: 7753563 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection of rat lymphocytes expressing human CD21 results in restricted latent viral gene expression and not in immunoblastic transformation. Yang L; Ikeda H; Lai Y; Yoshiki T; Takada K J Med Virol; 2003 May; 70(1):126-30. PubMed ID: 12629653 [TBL] [Abstract][Full Text] [Related]
15. Analysis and isolation of leukaemic and residual normal B lymphocyte populations from patients with chronic lymphocytic leukaemia. Murphy JJ; Tooze J; Millard RE; Hudson L Clin Exp Immunol; 1987 Jun; 68(3):669-76. PubMed ID: 3115650 [TBL] [Abstract][Full Text] [Related]
16. Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth. Gordon J; Walker L; Guy G; Brown G; Rowe M; Rickinson A Immunology; 1986 Aug; 58(4):591-5. PubMed ID: 2426189 [TBL] [Abstract][Full Text] [Related]
17. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype. Nilsson T; Sjöblom A; Masucci MG; Rymo L Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle. Teramoto N; Gogolák P; Nagy N; Maeda A; Kvarnung K; Björkholm T; Klein E J Hum Virol; 2000; 3(3):125-36. PubMed ID: 10881992 [TBL] [Abstract][Full Text] [Related]
19. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV. Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331 [TBL] [Abstract][Full Text] [Related]
20. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines. Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]